XML 35 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Statement of Cash Flows (USD $)
9 Months Ended118 Months Ended
Aug. 31, 2011
Aug. 31, 2010
Aug. 31, 2011
Operating Activities   
Net loss$ (2,352,160)$ (3,031,467)$ (59,543,937)
Cumulative effect of accounting change0099,481
Amortization of debt issue costs06,8257,500
Depreciation and accretion78,975163,6423,022,986
Loss on disposal of property and equipment00279,529
Stock-based compensation included in management fees003,375,644
Stock issued for debenture00217,687
Stock issued for consulting and other expenses885,893811,2667,796,962
Prepaid consulting fees expensed198,693716,8651,249,059
Stock issued for commitment fees00960,000
Financing expense075,000252,003
Accretion of discount on convertible debt312,511159,0151,219,951
Loss on derivative0100,02629,797
Gain on derecognition of convertible debt, promissory note and accrued interest(12,327)0(273,154)
Impairment of mineral claim expenditures001,159,529
Impairment of property and equipment00329,679
Impairment of leasehold improvements00340,821
Accretion on asset retirement obligation21,189(2,411)56,894
Changes in operating assets and liabilities:   
Cheques issued in excess of cash6,97006,970
Gold inventory6,31608,633
Prepaid expenses and deposits3,811(10,139)(42,765)
Accounts payable and accrued liabilities286,800285,543908,157
Advances to related party(191,281)(117,131)389,151
Net Cash Used in Operating Activities(754,610)(842,966)(38,149,423)
Investing Activities   
Purchase of restricted cash equivalent(9,189)0(9,189)
Investment in mineral properties and rights(99,080)(99,080)(1,466,022)
Purchase of property and equipment(58,711)(1,206)(3,139,830)
Proceeds from sale of property and equipment, net00825,299
Net Cash Used In Investing Activities(166,980)(100,286)(3,789,742)
Financing Activities   
Repayment of loans payable00(110,728)
Repayment of capital lease obligation00(1,131,607)
Proceeds from issuance of convertible debt, net0251,000570,000
Proceeds from issuance of promissory notes315,00050,000377,327
Share subscriptions received104,45333,250203,745
Proceeds from issuance of common stock, net431,877626,65741,782,029
Proceeds from exercise of warrants4,4940231,807
Net Cash Provided By Financing Activities855,824960,90741,922,573
Increase (Decrease) In Cash(65,766)17,655(16,592)
Cash - Beginning of Period66,267017,093
Cash - End of Period50117,655501
Supplemental Disclosures   
Interest paid073,8300
Income taxes paid$ 0$ 0$ 0